Literature DB >> 28118212

Delayed Anaphylaxis to Mammalian Meat Following Tick Exposure and Its Impact on Anesthetic Management for Cardiac Surgery: A Case Report.

Amanda M Kleiman1, Keith E Littlewood, Danja S Groves.   

Abstract

Hypersensitivity reactions to mammalian meat following tick exposure are increasing in prevalence and provide a unique challenge to anesthesiologists. The reactions, including anaphylaxis, are delayed and therefore may not be easily recognized and treated. The risk is especially high in cardiac surgery, where several potential triggers, including biological valves as well as heparin, are used frequently. In the presence of such hypersensitivity, prophylactic measures including preoperative testing and pharmacologic prophylaxis may be useful in modulating the immune response such that triggering agents may be used relatively safely. We present 3 patients with previous sensitization to meat protein following a tick bite with known allergic reactions to mammalian meat who presented for cardiac surgery involving exposure to potential allergens and discuss the perioperative management including possible prevention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28118212     DOI: 10.1213/XAA.0000000000000457

Source DB:  PubMed          Journal:  A A Case Rep        ISSN: 2325-7237


  3 in total

Review 1.  Diagnosis and Management of Patients with the α-Gal Syndrome.

Authors:  Thomas A E Platts-Mills; Rung-Chi Li; Behnam Keshavarz; Anna R Smith; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol Pract       Date:  2019-09-28

2.  Safety of Intravenous Heparin for Cardiac Surgery in Patients With Alpha-Gal Syndrome.

Authors:  Robert B Hawkins; Jeffrey M Wilson; J Hunter Mehaffey; Thomas A E Platts-Mills; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2020-10-05       Impact factor: 5.102

Review 3.  Environmental and Molecular Drivers of the α-Gal Syndrome.

Authors:  Alejandro Cabezas-Cruz; Adnan Hodžić; Patricia Román-Carrasco; Lourdes Mateos-Hernández; Georg Gerhard Duscher; Deepak Kumar Sinha; Wolfgang Hemmer; Ines Swoboda; Agustín Estrada-Peña; José de la Fuente
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.